The Hyperglycemia : Intensive Insulin Infusion In Infarction ( HI-5 ) Study A randomized controlled trial of insulin infusion therapy for myocardial infarction

@inproceedings{Boyages2009TheH,
  title={The Hyperglycemia : Intensive Insulin Infusion In Infarction ( HI-5 ) Study A randomized controlled trial of insulin infusion therapy for myocardial infarction},
  author={Steven Boyages and David R Chipps and Roselyn Crampton and Jeffrey R. Hazel and Jane Holmes-Walker and Jenny Marks and Doug T Ross and Hildegard K Smith},
  year={2009}
}
RESULTS — A total of 240 subjects were recruited. Insulin/dextrose infusion did not reduce mortality at the inpatient stage (4.8 vs. conventional 3.5%, P " 0.75), 3 months (7.1 vs 4.4%, P " 0.42), or 6 months (7.9 vs. 6.1%, P " 0.62). There was, however, a lower incidence of cardiac failure (12.7 vs. 22.8%, P " 0.04) and reinfarction within 3 months (2.4 vs. 6.1%, P " 0.05). When analyzed by mean BGL achieved during the first 24 h, mortality was lower among subjects with a mean BGL "8 mmol/l… CONTINUE READING